İnci Yaman BAJİN, Barış KUŞKONMAZ, Şule ÜNAL, Mualla ÇETİN, Selin ARDALI, Kader KARLI OĞUZ, Fatma GÜMRÜK
Stroke-Like Hemiparesis During Acute Lymphoblastic Leukemia Treatment
In this case report; a 12-year-old male with acute lymphoblastic leukemia who developed transient left hemiparesis associated with dysphasia and central facial paralysis 14 days after high dose methotrexate (5g/m2 ) and intrathecal methotrexate (12 mg, according to age) treatment has been reported. Cranial magnetic resonance imaging revealed restricted diffusion in bilateral centrum semiovale compatible with methotrexate-induced acute encephalopathy. All clinical symptoms resolved completely without any treatment. Clinical findings including headache, nausea, emesis, lethargy, altered mental status, blurred vision, aphasia, dysphasia, hemiparesis and cranial magnetic resonance imaging findings of restricted diffusion that does not comply with the territory of any artery should alert the physician for methotrexate-induced acute encephalopathy.
___
[1] Bhojwani D, Sabin ND, Peiet D et al. MethotrexateInduced Neurotoxicity and Leukoencephalopathy in Childhood Acute Lymphoblastic Leukemia. J Clin Oncol 2010; 32:949-9592.[2] Inaba H, Khan RB, Laningham FH, et al. Clinical and radiological characteristics of methotrexate-induced acute encephalopathy in pediatric patients with cancer. Ann Oncol. 2008;19(1):178-84.
[3] Yap SM, MacEneaney P, Ryan C, et al. Alternating hemiparesis and orolingualapraxia as manifestations of methotrexate neurotoxicity in a paediatric case of acutelymphoblastic leukaemia. . BMJ Case Rep. 2016 Apr 25. pii: bcr2016214677.
[4] Castillo L. Final Version of Therapy Protocol from August-14-2009. Start. 01.04.2010. End. 31.03.2015. ALL ICBFM 2009 – TRIAL STEERING COMMITTEE. www.bialaczka. org/wp content/uploads/2016/01/24_06_11_ALLIC_ BFM_2009.pdf
[5] Dufourg MN, Landman-Parker J, Auclerc MF, et al. Age and high-dose methotrexate are associated to clinical acute encephalopathy in FRALLE 93 trial for acute lymphoblastic leukemia in children. Leukemia 2007; 21:238-247.
[6] Rubnitz JE, Relling MV, Harrison PL, et al. Transient encephalopathy following high-dose methotrexate treatment in childhood acute lymphoblastic leukemia. Leukemia 1998; 12: 1176–1181.
[7] Walker RW, Allen JC, Rosen G, et al. Transient cerebral dysfunction secondary to high-dose methotrexate. J Clin Oncol 1986; 4: 1845–1850.
[8] Jaffe N, Takaue Y, Anzai T, et al. Transient neurologic disturbances induced by high-dose methotrexate treatment. Cancer 1985; 56: 1356–1360.
[9] Mahoney DH Jr, Shuster JJ, Nitschke R et al. Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy—a Pediatric Oncology Group study. J Clin Oncol 1998; 16: 1712–1722.
[10] Brugnoletti F, Morris EB, Laningham FH, et al. Recurrent intrathecal methotrexate induced neurotoxicity in an adolescent with acute lymphoblastic leukemia: Serial clinical and radiologic findings. Pediatr Blood Cancer. 2009;52(2):293-5.
[11] James MF, Smith MI, Bockhorst KH et al. Cortical spreading depression in the gyrencephalic feline brain studied by magnetic resonance imaging. J Physiol 1999; 519 Pt 2: 415–425.
[12] Bernini JC, Fort DW, Griener JC et al. Aminophylline for methotrexate-induced neurotoxicity. Lancet 1995; 345: 544–547.
- ISSN: 2147-9488
- Yayın Aralığı: Yılda 4 Sayı
- Başlangıç: 2012
- Yayıncı: HACETTEPE ÜNİVERSİTESİ
Sayıdaki Diğer Makaleler
Ulas KUMBASAR, EMİNE İPEK ÖZBEK SÖNMEZ, Zeynelabidin OZTURK, Recep Oktay PEKER, Saniye EKİNCİ, Benan BAYRAKCİ, Mustafa YİLMAZ, Riza DOGAN
Asena Gökçay CANPOLAT, Demet ÇORAPÇIOĞLU
Aquaporins: A Multidisciplinary Perspective on the Water Channel Proteins
Gokce ALP, Ipek BOSGELMEZ, Yesim OZTAS
Stroke-Like Hemiparesis During Acute Lymphoblastic Leukemia Treatment
İnci Yaman BAJİN, Barış KUŞKONMAZ, Şule ÜNAL, Mualla ÇETİN, Selin ARDALI, Kader KARLI OĞUZ, Fatma GÜMRÜK